Mylan Aktie
WKN: 868270 / ISIN: US6285301072
30.12.2016 18:22:59
|
Mylan Posting Strong Gain After Launching Generic Concerta, Cerebyx
(RTTNews) - Mylan (MYL) is posting a strong gain in afternoon trading on Friday, with shares of the drug maker climbing by 2.5 percent. Earlier in the session, Mylan reached its best intraday level in well over a month.
The gain by Mylan comes after the company announced the launch of a generic version on Johnson & Johnson's (JNJ) Concerta tablets for the treatment of Attention Deficit Hyperactivity Disorder.
Mylan also announced the launch of a generic version of Pfizer's (PFE) Cerebyx injection for the treatment of certain types of severe seizures.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Mylan Incmehr Nachrichten
Keine Nachrichten verfügbar. |